Key Dates

February 22, 2024 - Notice of Information: Reissuance of the Suite of Notices of Funding Opportunities (NOFOs) for the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) Program . See Notice NOT-TR-24-008. 

February 22, 2024 - Notice of Intent to Publish a Funding Opportunity Announcement for Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional). See Notice NOT-TR-24-009. 

February 22, 2024 - Notice of Intent to Publish a Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed). See Notice NOT-TR-24-010. 

February 22, 2024- Notice of Intent to Publish a Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed). See Notice NOT-TR-24-011. 

February 22, 2024 - Notice of Intent to Publish a Funding Opportunity Announcement for Re-issue of PAR-21-336 Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional). See Notice NOT-TR-24-012.

National Center for Advancing Translational Sciences (NCATS)

The National Center for Advancing Translational Sciences (NCATS) intends to reissue the Notice of Funding Opportunity (NOFO) to solicit applications to provide support to recipients of Clinical and Translational Science Awards (CTSA) for creative educational activities with a primary focus on research experiences designed to ensure that the participants receive exposure to the scientific and operational principles underlying each step of the translational process so that they can apply these principles to clinical and translational science research areas such as: 1) pre-clinical research, 2) clinical research, 3) clinical implementation, and 4) public health.  

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.  

The NOFO is expected to be published in Summer 2024 with an expected application due date in January 2025. 

This NOFO will utilize the R25 activity code. Details of the planned NOFO are provided below. 

The overarching goal of this R25 program is to provide support to recipients of Clinical and Translational Science Awards (CTSA) for research experiences that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish this over-arching goal, this NOFO will support creative educational activities with a primary focus on: 

• Research Experiences: 
  • Research experiences are expected to be relevant to NCATS mission of studying translation on a system-wide level, agnostic to a specific disease, to better understand the scientific and operational principles underlying each step of the translational process. The goal is not to focus on specific diseases, but on what is common among them and the translational science process. Examples of research experiences appropriate for career levels include, but are not limited to: 
    • Undergraduates: to provide hands-on exposure to research that reinforces their interest in clinical and translational science and/or prepares them for graduate school matriculation and/or careers in clinical and translational science for graduate and medical, dental, nursing and other health professional students. 
    • Postdoctoral Fellows and Medical Residents: to extend their skills, experiences, and knowledge base in order to engage in clinical and translational science research activities. 
    • Junior Faculty: to enhance their research skills, experiences, and knowledge base relative to clinical and translational science by working with faculty members at a partnering institution. 
• Proposed research experiences should involve an innovative approach to provide hands-on exposure to clinical and translational science research in a laboratory or a field setting for a full-time (40 hours per week) period of 10 to 15 weeks in order to stimulate the interest and advance the knowledge base of participants to consider further education and training for future careers as clinical and translational science researchers. The proposed programs should provide research experiences that are not available through formal NIH training mechanisms. 
• R25 programs that propose at least 10 weeks, but fewer than 15 weeks, of full-time research experiences are allowed to request continued part-time support for the participants to work on their research projects, up to the equivalent of 15 weeks of full-time participation, as long as the entire research experience is completed within a 12-month period. Successful participants may be appointed for additional periods of short-term research experiences. 

Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g., T32, T90) but cannot be used to replace or circumvent Ruth L. Kirschstein National Research Service Award (NRSA) programs.

Funding Information

Applications are not being solicited at this time. 

Inquiries

Please direct all inquiries to:

Jamie Doyle, Ph.D. 
National Center for Advancing Translational Sciences (NCATS) 
Telephone: 301-402-0403 
Email: [email protected]